BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.03
+0.18 (0.52%)
May 9, 2025, 10:58 AM - Market open
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $6.65 billion as of May 9, 2025. Its market cap has increased by 41.64% in one year.
Market Cap
6.65B
Enterprise Value
7.93B
1-Year Change
41.64%
Ranking
Category
Stock Price
$35.03
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $6.65B, an increase of 100.36%. That is a compound annual growth rate of 12.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.82B |
| Johnson & Johnson | 372.12B |
| UnitedHealth Group | 359.23B |
| AbbVie | 331.24B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.49B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |